openPR Logo
Press release

Carbapenem-based Antibiotics Market to Exhibit 7% CAGR, with Sales of Tebipenem and Sulopenem Projected to Soar

01-21-2021 12:48 PM CET | Health & Medicine

Press release from: Fact.MR

Carbapenem-based Antibiotics Market

Carbapenem-based Antibiotics Market

Incidence of bacterial infections with multidrug resistance is increasing rapidly, generating the need for novel, broad-spectrum carbapenem-based antibiotics for the treatment of various bacterial infections. Broad-spectrum carbapenem-based antibiotics such as tebipenem (Spero Therapeutics Inc.) and sulopenem (Iterum Therapeutics Inc.) are at late stage clinical development with expected launch of both in 2020 - 2021.

Multidrug resistance to currently marketed carbapenem-based antibiotics is largely prevalent in the world. Also, expiry of patent for ertapenem is expected to offer new avenues for market growth in regulated as well as non-regulated carbapenem-based antibiotics market where its adoption & availability are comparatively limited. On the back of these factors, the global carbapenem-based antibiotics market is estimated to reach a valuation of US$1.8 Bn by 2029.

Request a report sample to gain comprehensive market insights at

Key Takeaways of Carbapenem-based Antibiotics Market Study

• Larger patient pools and launch of novel products for the treatment of bacterial infections are expected to shape the carbapenem-based antibiotics market landscape.
• Increasing prevalence of bacterial infections caused by longer stay in hospitals as well as immunocompromising chronic diseases that make patients prone to bacterial infections is expected to boost carbapenem-based antibiotics market growth.
• Currently, the carbapenem-based antibiotics market is dominated by ertapenem. However, tebipenem is expected to gain traction during the forecast period in terms of revenue.
• In terms of indication, pneumonia is expected to garner highest market share as compared to other bacterial infections owing to a large patient pool.

For information on the Research Approach used in the Report, Request Methodology@

“ Recently, FDA granted Qualified Infectious Disease Product (QIDP) to sulopenem as well as tebipenem for new indications, which is further expected to broaden the growth prospect of the carbapenem-based antibiotics market," says the Fact.MR Analyst.

Strategic Expansion by Dominant Players Benefiting Market

The carbapenem-based antibiotics market is dominated by top three players including Merck Co. & Inc., Pfizer Inc., and Sumitomo Dainippon Pharma Co., Ltd. These leading players in the carbapenem-based antibiotics market contribute around 80% to 90% revenue share. Clinical stage companies such as Spero Therapeutic Inc. and Iterum Therapeutics Inc. with the launch of their novel carbapenem-based antibiotics are expected to acquire significant market space. In October 2017, Spero Therapeutics, Inc. and Meiji Seika Pharma Co., Ltd. announced an exclusive licensed partnership for its carbapenem-based antibiotic named SPR994 (tebipenem). In a similar development, Sumitomo Dainippon Pharma in June 2017, announced a partnership with Zuellig Pharma for sales of carbapenem-based antibiotic meropenem in five countries of Southeast Asia (Vietnam, Thailand, Singapore, Philippines, Malaysia) and Hong Kong.

Looking for more information?

The research study on carbapenem-based antibiotics market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends which have shaped the landscape of carbapenem-based antibiotics over 2014 - 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 - 2029. Market statistics have been presented on the basis of product type (Meropenem, imipenem, ertapenem, tebipenem, doripenem, panipenem, etc.), indication (intra-abdominal infections, urinary tract infections, pneumonia, bacterial meningitis, skin and skin structure infections, acute pelvic infections, prophylaxis of surgical site infection, respiratory tract infections, others), sales channel (hospital pharmacies, retail pharmacies, online pharmacies) across seven major regions.

Get Full Access of the Report @

Fact.MR’s Domain Knowledge in Healthcare
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

Unit No: AU-01-H
Gold Tower (AU)
Plot No: JLT-PH1-I3A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
Contact: +353-1-6111-593
Website :

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports.
We believe transformative intelligence can educate and inspire businesses to make smarter decisions.
We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carbapenem-based Antibiotics Market to Exhibit 7% CAGR, with Sales of Tebipenem and Sulopenem Projected to Soar here

News-ID: 2228953 • Views: 913

More Releases from Fact.MR

Edge Computing Market Key-Players, Growth Analysis and Forecast to 2030 | Cisc …
The global edge computing market is projected to expand with a massive 30% CAGR between the period of projection from 2020 to 2030. The Fact.MR report states that, edge computing networking technologies are rapidly gaining traction during the coronavirus pandemic as network traffic has shifted substantially from commercial infrastructure to residential infrastructure. In addition, government initiatives to track the spread of the contagion has created niche opportunities for edge computing
Refractories Market Drivers, Growth, Size and Opportunities Forecast 2020-2030 …
The refractories market is anticipated to expand with a moderate 4% CAGR during 2020 to 2030. The Fact.MR report states that the rapid rise in coronavirus cases in major iron and steel manufacturing countries such as China and India have had an adverse impact on the demand for refractory products in the short term. However, strong activity in manufacturing and construction industries will aid a strong recovery towards the end
Medical Mask Market Key Manufacturer, Industry Revenue and Gross Profit Till 20 …
Healthcare facilities around the world are preparing to keep up with the surge in coronavirus patients. Governments are highly concerned about the capabilities of existing healthcare infrastructure. Shortages of medical supplies are putting patients, doctors, and nurses at risk. The shortages of N-95 masks in particular is gaining attention owing to its importance in healthcare settings. The global medical mask market is expected to expand at an impressive 9.6% CAGR throughout
Hand Sanitizer Market Predicted to Grow at a Moderate Pace Through 2030 | Kimb …
Rising consumer inclination towards personal hygiene is driving demand for hand sanitizers amid the global COVID-19 pandemic. While outbreak driven lockdowns and stay-at-home orders initially led to panic buying and stockpiling of hand sanitizer and other hygiene products in Q1 2020, shortages and price hike were the latter repercussions. A new Fact.MR report projects a strong growth outlook for hand sanitizer market, with 1.9X expansion in revenues over 2020 -

All 5 Releases

More Releases for Antibiotics

Antibiotics Market Excellent Growth 2021 Top Key Players | Antibiotics market a …
Antibiotics Market Overview: The market research report on the Global Antibiotics Market offered by Straits Research, analyses the major opportunities, CAGR, yearly growth rates to help the readers to understand the qualitative and quantitative aspects of the Global Antibiotics Market. The competition landscape, company overview, financials, recent developments and long-term investments related to the Global Antibiotics Market are mentioned in this report. Various parameters have been studied while estimating the market size. The revenue
Global Antibiotics Market Overview 2019-2025
The global antibiotics market is expected to reach USD 40.78 billion by 2025. Increasing prevalence of infectious diseases worldwide is a major factor driving the global antibiotics market. Since the discovery of antibiotics in the early 20th century, these have been an essential tool in treating the massive burden of infectious diseases worldwide. Yet antimicrobial resistance or AMR is increasingly threatening the effectiveness of antibiotics, which may restrain their use. Major
Peptide Antibiotics Global Industry Report - History, Present and Future 2025
The global market size of Peptide Antibiotics is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented
Global MRSA Antibiotics Market: Scenario 2025
“Global MRSA Antibiotics Industry Report" is an expert and in-depth analysis of key business and future development prospects, key determinants and restrictions, profiles of major market players, segmentation and forecasting. The study offers a comprehensive qualitative analysis of the industry's growth parameters, the current state of the market in terms of analysis of key economic situations and macroeconomic analysis. The analysis highlights the growth opportunities of key market segments along
Animal Pharm Antibiotics in Animal Production 2016
ReportsWorldwide has announced the addition of a new report title Animal Pharm Antibiotics in Animal Production 2016 to its growing collection of premium market research reports. The global market size for antibiotics use in animal production is large and consumption is projected to reach 105 596 tonnes by 2030. However, extensive evidence now reveals the contribution that antibiotic use has made to the development of antibiotic resistance and its resultant consequences
Animal Antibiotics Market 2017- Zoetis Elanco, Merial’s Animal Antibiotics market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Request for sample @ The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and